Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections

References

• AhrensJWiedenbachM1984[Efficacy of the immunostimulant Broncho-Vaxom] Schweiz Med Wochenschr1142593246379870
   PubMed Web of Science ®Google Scholar
• AllegraLCordaroCIGrassiC1996Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trialRespiration63174808739489
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyStandards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Adopted by the ATS Board of Directors, November 1986Am Rev Respir Dis1987136225443605835
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCP1987Antibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med1061962043492164
   PubMed Web of Science ®Google Scholar
• BomanGBackerULarssonS1983Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary DiseasesEur J Respir Dis64405156350033
   PubMedGoogle Scholar
• British Thoracic Society Research Committee1985Oral Nacetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstructionThorax4083252866607
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPW2000Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ320129730310807619
   PubMed Web of Science ®Google Scholar
• CabelloHTorresACelisR1997Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic studyEur Respir J101137449163659
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJ2003Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet36144956(a)12583942
   PubMed Web of Science ®Google Scholar
• CalverleyPMBoonsawatWCsekeZ2003Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J2269129(b).14680078
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeW2004Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J239324615219010
   PubMed Web of Science ®Google Scholar
• ChrystynHMulleyBAPeakeMD1988Dose response relation to oral theophylline in severe chronic obstructive airways diseaseBMJ2971506103147048
   PubMed Web of Science ®Google Scholar
• ColletJPDucruetTKramerMS1993Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicreche Research GroupPediatr Infect Dis J128648528414777
   PubMed Web of Science ®Google Scholar
• ColletJPShapiroPErnstP1997Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an ImmunostimulantAm J Respir Crit Care Med15661719249412546
   PubMed Web of Science ®Google Scholar
• CvoriscecBUstarMPardonR1989Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre studyRespiration553129352682862
   PubMed Web of Science ®Google Scholar
• DahlRGreefhorstLANowakD2001Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1647788411549532
   PubMed Web of Science ®Google Scholar
• DavisALArandaCPSchiffmanG1987Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot studyChest92204123608590
   PubMed Web of Science ®Google Scholar
• DebbasNDerenneJP1990Preventive effects of an immunostimulating product on recurrent infections of chronic bronchitis in the elderlyLung168Suppl737402117186
   PubMed Web of Science ®Google Scholar
• Del-Rio-NavarroBELuis Sienra-MongeJJBerberA2003Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levelsAllergol Immunopathol (Madr)31171312573204
   PubMedGoogle Scholar
• DebelicMEckenbergerHP1992[Prevention of recurrent infection of the upper and lower airwaysMulticenter, open study over three months] Fortschr Med11030565701468743
   PubMedGoogle Scholar
• DeverLLShashikumarKJohansonWGJr2002Antibiotics in the treatment of acute exacerbations of chronic bronchitisExpert Opin Investig Drugs11791125
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTARBhowmikA2002Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax578475212324669
   PubMed Web of Science ®Google Scholar
• EdwardsKMDupontWDWestrichMK1994A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A diseaseJ Infect Dis16968768277200
   PubMed Web of Science ®Google Scholar
• FileTM2000The epidemiology of respiratory tract infectionsSemin Respir Infect1531849411052419
   PubMedGoogle Scholar
• FletcherCMBallJDCarstairsLW1966Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the Medical Research Council by their Working Party on trials of chemotherpay in early chronic bronchitisBMJ154991317225327220
   PubMedGoogle Scholar
• FrancisRSSpicerCC1960Chemotherapy in chronic bronchitis: influence of daily penicillin and teracycline on exacerbations and their cost. A report to the research committee of the British Tuberculosis Assoication by their Chronic Bronchitis subcommitteeBMJ129730313824401
   PubMed Web of Science ®Google Scholar
• FrancisRSMayJRSpicerCC1961Chemotherapy of bronchitis: influence of penicillin and tetracylcline administered daily, or intermittently for exacerbationsBMJ29798513894512
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseUpdate 1 July 2005. A collaborative project of the National Health L, and Blood Institute, NIH and the World Health Organisation, ed wwwgoldcopdcom: National Institutes of Health, National Heart Lund and Blood Institute Bethesda, Md2005
   Google Scholar
• Gomez BarretoDDe la TorreCAlvarezA1998[Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children]Allergol Immunopathol (Madr)26117229585823
   PubMedGoogle Scholar
• GrossNJPettyTLFriedmanM1989Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center studyAm Rev Respir Dis1391188912523681
   PubMed Web of Science ®Google Scholar
• Gutierrez-TarangoMDBerberA2001Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 monthsChest11961742811399700
   PubMed Web of Science ®Google Scholar
• GuyattGHTownsendMPugsleySO1987Bronchodilators in chronic airflow limitation. Effects on airway function, exercise capacity, and quality of lifeAm Rev Respir Dis135106974(a).3579005
   PubMed Web of Science ®Google Scholar
• GuyattGHTownsendMKazimF1987A controlled trial of ambroxol in chronic bronchitisChest9261820(b).3308343
   PubMed Web of Science ®Google Scholar
• HakEvan EssenGABuskensE1998Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The NetherlandsJ Epidemiol Community Health5212059578860
   PubMed Web of Science ®Google Scholar
• HananiaNADarkenPHorstmanD2003The efficacy and safety of fluticasone propionate (250microg)/salmeterol(50microg) combined in the Diskus inhaler for the treatment of COPDChest12438344312970006
   PubMed Web of Science ®Google Scholar
• HansenNCSkriverABrorsen-RiisL1994Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitisRespir Med8853157972979
   PubMed Web of Science ®Google Scholar
• HeintzBSchlenterWWKirstenR1989Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis — a multi-centric, placebo-controlled, double-blind studyInt J Clin Pharmacol Ther Toxicol271153042693373
   PubMed Web of Science ®Google Scholar
• HigginsBGPowellRMCooperS1991Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitisEur Respir J4415201830277
   PubMed Web of Science ®Google Scholar
• HillemanDEDewanNMaleskarM2000Pharmacoeconomic evaluation of COPDChest11812788511083675
   PubMed Web of Science ®Google Scholar
• IkedaANishimuraKKoyamaH1995Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide aloneChest10740157842768
   PubMed Web of Science ®Google Scholar
• IrwinRSBouletLPCloutierMM1998Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest PhysiciansChest114133S181S9725800
   PubMed Web of Science ®Google Scholar
• IsadaCMStollerJK1994Chronic bronchitis: the role of antibioticsNiedermanMSSarosiGAGlassrothJRespiratory infections: a scientific basis for managementLondonWB Saunders62133
   Google Scholar
• JohnstonRNMcNeillRSSmithDH1969Five-year winter chemoprophylaxis for chronic bronchitisBr Med J426594899454
   PubMed Web of Science ®Google Scholar
• JonesPWWillitsLRBurgePS2003Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbationsEur Respir J21687312570111
   PubMed Web of Science ®Google Scholar
• KellerR1984[Multicenter double-blind study of the action of Broncho-Vaxom in chronic bronchitis]Schweiz Med Wochenschr1142593476379871
   PubMedGoogle Scholar
• The Lung Health Study Research Group2000Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease: Lung Health Study IIN Engl J Med3431902911136260
   PubMed Web of Science ®Google Scholar
• LiJZhengJPYuanJP2004Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary diseaseChin Med J (Engl)11768283415198881
   PubMed Web of Science ®Google Scholar
• MacchiAVecchiaLD2005Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infectionsArzneimittelforschung5552768115960427
   PubMed Web of Science ®Google Scholar
• MahlerDADonohueJFBarbeeRA1999Efficacy of salmeterol xinafoate in the treatment of COPDChest1159576510208192
   PubMed Web of Science ®Google Scholar
• MahlerDAWirePHorstmanD2002Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med166810849112379552
   PubMed Web of Science ®Google Scholar
• ManWDMustfaNNikoletouD2004Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPDThorax596471615170026
   PubMed Web of Science ®Google Scholar
• MiravitllesMMayordomoCArtésM1999Treatment of chronic obstructive pulmonary disease and its exacerbations in general practiceRespir Med93173910464874
   PubMed Web of Science ®Google Scholar
• NicholKLMargolisKLWuorenmaJ1994The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the communityN Engl J Med331778848065407
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlugeTGerkenF2004Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J, Jun23683240
   PubMed Web of Science ®Google Scholar
• OostenbrinkJBRutten-van MolkenMPAlMJ2004One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary diseaseEur Respir J232241914979498
   PubMed Web of Science ®Google Scholar
• OrcelBDelclauxBBaudMOral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitisEur Respir J73446528013600
   PubMed Web of Science ®Google Scholar
• PapiALuppiFFrancoF2006Pathophysiology of exacerbations of chronic obstructive pulmonary diseaseProc Am Thorac Soc332455116636093
   PubMedGoogle Scholar
• PatelISSeemungalTARWilksMLloy2002Relationship between bacterial colonisation and the frequency, character and severity of COPD exacerbationsThorax577596412200518
   PubMed Web of Science ®Google Scholar
• PauwelsRALofdahlCGLaitinenLA1999Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med34019485310379018
   PubMed Web of Science ®Google Scholar
• PettyTL1990The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitisChest9775832403903
   PubMed Web of Science ®Google Scholar
• PoolePJBlackPN2003Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev2CD00128712804402
   PubMedGoogle Scholar
• RasmussenJBGlennowC1988Reduction in days of illness after longterm treatment with N-acetylcysteine controlledrelease tablets in patients with chronic bronchitisEur Respir J135153294038
   PubMed Web of Science ®Google Scholar
• RosaschinoFCattaneoL2004Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered polyvalent mechanical bacterial lysates (PMBL)Acta Biomed Ateneo Parmense7531718
   PubMedGoogle Scholar
• RuahSBRuahCvan AubelA2001Efficacy of a polyvalent bacterial lysate in children with recurrent respiratory tract infectionsAdv Ther1841516211697018
   PubMed Web of Science ®Google Scholar
• RutishauserMPitzkePGreversG1998Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind studyAdv Ther1563304110351117
   PubMed Web of Science ®Google Scholar
• SchaadUBMutterleinRGoffinHBV-Child Study Group2002Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter studyChest12262042912475845
   PubMed Web of Science ®Google Scholar
• SeemungalTARDonaldsonGCPaulEA1998Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1571418229603117
   PubMed Web of Science ®Google Scholar
• SeemungalTHarper-OwenRBhowmikA2001Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med164916182311719299
   PubMed Web of Science ®Google Scholar
• SethiSMurphyTF2001Bacterial infection in chronic obstructive pulmonary disease in 2000: a state of the art reviewClin Microbiol Rev143366311292642
   PubMed Web of Science ®Google Scholar
• SiafakasNMVermeirePPrideNB1995Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEur Respir J813984207489808
   PubMed Web of Science ®Google Scholar
• SiafakasNMBourosD1998Management of acute exacerbation of chronic obstructive pulmonary diseasePostmaDSSiafakasNMManagement of chronic obstructive pulmonary diseaseSheffield: ERS Monograph26477
   Google Scholar
• SimberkoffMSCrossAPAl-IbrahimM1986Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative StudyN Engl J Med3151318273534568
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMBurgePS2004Impact of preventing exacerbations on deterioration of health status in COPDEur Respir J23569870215176682
   PubMed Web of Science ®Google Scholar
• SramekJJosifkoMHelclJ1986Bacterial lysate (I.R.S. 19) applied intranasally in the prevention of acute respiratory diseases in children: a randomized double-blind studyJ Hyg Epidemiol Microbiol Immunol30437785
   PubMedGoogle Scholar
• Steurer-SteyCBachmannLMSteurer2004Oral purified bacterial extracts inchronic bronchitis and COPD: Systematic ReviewChest12616455515539739
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezA2002Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J21748112570112
   PubMed Web of Science ®Google Scholar
• TielemansCGastaldelloKHussonC1999Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: a double-blind, placebo-controlled studyClin Nephrol5131536010099888
   PubMed Web of Science ®Google Scholar
• TricaricoDVarricchioAD’AmbrosioSAscioneEMottaG2004Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trialArzneimittelforschung541576314979610
   PubMed Web of Science ®Google Scholar
• VathenenASBrittonJREbdenP1998High-dose inhaled albuterol in severe chronic airflow limitationAm Rev Respir Dis13885052462383
   PubMed Web of Science ®Google Scholar
• VestboJSorensenTLangeP1999Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet35318192310359405
   PubMed Web of Science ®Google Scholar
• VinckenWvan NoordJAGreefhorstAP2002Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J192091611871363
   PubMed Web of Science ®Google Scholar
• WongsurakiatPLertakyamaneeJMaranetraKN2003Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patientsJ Med Assoc Thai86649750812924797
   PubMedGoogle Scholar
• WongsurakiatPMaranetraKNWasiC2004Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled studyChest125620112015189916
   PubMed Web of Science ®Google Scholar
• WilliamsJHJMoserKM1986Pneumococcal vaccine and patients with chronic lung diseaseAnn Intern Med10410693940477
   PubMed Web of Science ®Google Scholar
• ZagarSLofler-BadzekD1989Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trialORL J Otorhinolaryngol Relat Spec5063974043068610
   PubMed Web of Science ®Google Scholar